A Q&A with Lucy Zhao, manager of the Skin Lab at CPL discusses the importance of in-vitro Release Testing and how it supports topical drug development.
Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standards